期刊文献+

SARS患者在疾病早期CD4^+T细胞减少及其临床意义 被引量:2

The decrease of CD4^+ T cells of patients with SARS in early stage and its clinical significance
下载PDF
导出
摘要 目的 :观察SARS患者在疾病早期CD4 + 细胞的改变及其在疾病的发展及治疗选择中的临床意义。方法 :流式细胞仪方法对 5 2例发病 10天内确诊为SARS患者的外周血标本进行T细胞亚群的绝对计数检测并动态观察胸部X光病变的变化及疾病转归。结果 :在 5 2例患者中 ,有 34例CD4 + 细胞绝对数在正常范围内的患者 ,病变范围小、病情呈稳定状态 ,病变吸收快 ,不需要肾上腺糖皮质激素治疗 ;另有 18例患者出现CD4 + 细胞的绝对值低于正常 ,其中有 13例患者病情呈进展状态 ,加用肾上腺糖皮质激素治疗 ,有 5例CD4 + 细胞绝对数轻度减低患者 ,病情处于稳定状态 ,未加用肾上腺糖皮质激素治疗。两组CD4 + 细胞数经统计学分析P =0 0 0 0 ;CD4 + 细胞数与肺内病变程度的Pearson相关性检验结果为r =- 0 737;P =0 0 0 0 ;与糖皮质激素应用的Pearson相关性检验结果为r =- 0 5 73;P =0 0 0 0。结论 :①SARS患者发病早期外周血CD4 + 细胞绝对计数与肺内病变的程度呈良好的负相关 ;②CD4 + 细胞绝对数下降明显者需糖皮质激素治疗。 Objective:To observe the change of CD4 + T cells of SARS patients in early stage of disease and determine its clinical significance on the progress of disease and therapy selection.Methods:Detection the absolute counts of T cell subset from the peripheral blood samples of 52 SARS patients in initial 10 days' duration by Flow cytometry.Serial frontal chest radiographs had done and the progression of disease was observed during the treatment of all patients.Results:The 34 cases among the 52 patients were in normal range of CD4 + cell absolute count.At the same time,their pulmonary lesions were in limited degree and the states of an illness were stabilization and the pulmonary lesions were absorbed quickly.Therefore they reuired the treatment without corticosteroids.The other 18 patients were with low CD4 + cell absolute count, of which 13 cases showed progressive deterioation of radiographic change and were treated with corticosteroids additional.The other 5 cases with the mild low of absolute count of CD4 + cells were also static during the period of observation,and no treatment with coticosteroids.There was statistically significant relation between two groups(P=0 000).The results of Pearson correlate analysis between absolute count of CD4 + cells and pulmonary lesions were r=-0 737;P=0 000;The result between absolute count of CD4 + cells and corticosteroids treatment were r=-0 573;P=0 000.Conclusion:Peripheral blood CD4 + cell absolute counts of SARS patients on early stage of onset were negatively related to the degree of pulmonary lesions.The patients with remarkable decrease of CD4 + cell were in need of treatment with corticosteroids.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2003年第7期452-454,共3页 Chinese Journal of Immunology
关键词 SARS 疾病早期 CD4^+T细胞减少 糖皮质激素 肺内病变 非典型肺炎 SARS CD4 + T cell Pulmonary lesion Corticosteroids
  • 相关文献

参考文献1

二级参考文献25

  • 1Fisher DA, Chew MH, Lim YT, Tambyah PA. Preventing local transmission of SARS: lessons from singapore. Med J Aust 2003;178:555-558.
  • 2Stohr K. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003; 361:1730-1733.
  • 3So LK, Lau AC, Yam LY, Cheung TM, Poon E, Yung RW, Yuen KY. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003; 361:1615-1617.
  • 4The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308.
  • 5Allegra L, Blasi F. Problems and perspectives in the treatment of respiratory infections caused by atypical pathogens. Pulm Pharmacol Ther 2001; 14:21-27.
  • 6Atabai K, Matthay MA. The pulmonary physician in critical care.5: Acute lung injury and the acute respiratory distress syndrome:definitions and epidemiology. Thorax 2002; 57:452-458.
  • 7Cordingley JJ, Keogh BF. The pulmonary physician in critical care. 8: Ventilatory management of ALI/ARDS. Thorax 2002; 57:729-734.
  • 8Moller JC, Schaible T, Roll C, Schiffmann JH, Bindl L, Schrod L,Reiss I, Kohl M, Demirakca S, Hentschel R, Paul T, Vierzig A,Groneck P, Von Seefeld H, Schumacher H, Gortner L. Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. Intensive Care Med 2003; 29:437-446.
  • 9Riley S, Fraser C, Donnelly CA, Ghani AC, Abu-Raddad LJ,Hedley AJ, Leung GM, Ho LM, Lam TH, Thach TQ, Chau P,Chan KP, Lo SV, Leung PY, Tsang T, Ho W, Lee KH, Lau EM,Ferguson NM, Anderson RM. Transmission dynamics of the etiological agent of SARS in hong kong: impact of public health interventions. Science 2003: [epub ahead of print].
  • 10Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L,Gopalakrishna G, Chew SK, Tan CC, Samore MH, Fisman D,Murray M. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003: [epub ahead of print].

共引文献25

同被引文献28

  • 1罗晓明,周馥英,周永列,王欣欣.婴幼儿呼吸道疾病B淋巴细胞状况分析[J].现代免疫学,2004,24(5):424-426. 被引量:3
  • 2国家SARS防治紧急科技行动北京组,王辰,夏成青.传染性非典型肺炎患者外周血CD4+T细胞CD38的表达及意义[J].中华检验医学杂志,2005,28(8):809-812. 被引量:2
  • 3吴长有,杨利桃.SARS病人的免疫应答[J].中华微生物学和免疫学杂志,2005,25(11):953-956. 被引量:4
  • 4王军,于岩岩,聂立功.40例重症SARS患者乳酸脱氢酶的变化与预后[J].实用心脑肺血管病杂志,2006,14(8):651-652. 被引量:2
  • 5Centers for Disease Control and Prevention (CDC). Update: inteetions with a swine-origin influenza A (HINI) virus--United States and other eountries, April 28, 2009 [J]. MMWR Morb Mortal WHy Rep,2009,58(16) :431-433.
  • 6Taubenberger JK, Morens DM. 1918 influenza : themotherofallpandemics[J]. Emerg Infect Dis ,2006, 12( 1 ) : 15-22.
  • 7McFee RB. Avian influenza: the nexl pandemic? [J]. Dis Mon, 2007,53 (7) : 348-387.
  • 8McCullers JA. New influenza A ( H 1N 1 ) virus-updale [J]. Wkly Epidemiol Rec, 2009,84( 19 ) : 171 - 172.
  • 9Maines TIt, Jayaraman A. Belser JA, el al. Transmission and palhogenesis of swine-origin 2009 A(H1N1) infue, nza viruses in lerrets and mice [J]. Science, 2009,325 ( 5939 ) : 484-487.
  • 10Hancock K, Veguilla V, Lu X, el al. Cross-reaelive anlihody responses to lhe 2009 pandemic H1N1 influenza virus [J ]. N Engl J Med,2009,361 (20) : 1945-1952.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部